ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma[1].
Molecular Weight:
982.74
CAS Number:
[1883817-83-1]
Formula:
C40H44F5IN10O6
Target:
p38 MAPK,PI3K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
